TLR3 activation augments matrix metalloproteinase production through reactive nitrogen species generation in human lung fibroblasts

Journal of Immunology

Volumn 192, Issue 11, 2014, Pages 4977-4988

  Ichikawa, Tomohiro ^a   Sugiura, Hisatoshi ^b   Koarai, Akira ^b   Minakata, Yoshiaki ^a   Kikuchi, Takashi ^a   Morishita, Yukiko ^a   Oka, Asako ^a   Kanai, Kuninobu ^a   Kawabata, Hiroki ^a   Hiramatsu, Masataka ^a   Akamatsu, Keiichiro ^a   Hirano, Tsunahiko ^a   Nakanishi, Masanori ^a   Matsunaga, Kazuto ^a   Yamamoto, Nobuyuki ^a   Ichinose, Masakazu ^b  

^a WAKAYAMA MEDICAL UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DOUBLE STRANDED RNA; GELATINASE A; GELATINASE B; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERFERON REGULATORY FACTOR 3; INTERSTITIAL COLLAGENASE; NITRIC OXIDE SYNTHASE INHIBITOR; POLYINOSINIC POLYCYTIDYLIC ACID; REACTIVE NITROGEN SPECIES; TOLL LIKE RECEPTOR 3;

ARTICLE; ASTHMA; CELL NUCLEUS; CONTROLLED STUDY; ENZYME RELEASE; HUMAN; HUMAN CELL; INTRACELLULAR SIGNALING; INTRACELLULAR TRANSPORT; LUNG FIBROBLAST; NITROSATIVE STRESS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

AIRWAY REMODELING; ASTHMA; CELL LINE, TUMOR; COLLAGENASES; FIBROBLASTS; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; INTERFERON INDUCERS; INTERFERON REGULATORY FACTOR-3; LUNG; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE II; POLY I-C; TOLL-LIKE RECEPTOR 3; VIRUS DISEASES;

EID: 84901259278     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1302919     Document Type: Article

References (55)

1. Bacharier, L. B., R. Cohen, T. Schweiger, H. Yin-Declue, C. Christie, J. Zheng, K. B. Schechtman, R. C. Strunk, and M. Castro. 2012. Determinants of asthma after severe respiratory syncytial virus bronchiolitis. J. Allergy Clin. Immunol. 130: 91-100, e3.
2. Singh, A. M., P. E. Moore, J. E. Gern, R. F. Lemanske, Jr., and T. V. Hartert. 2007. Bronchiolitis to asthma: a review and call for studies of gene-virus interactions in asthma causation. Am. J. Respir. Crit. Care Med. 175: 108-119.
3. Busse, W. W., R. F. Lemanske, Jr., and J. E. Gern. 2010. Role of viral respiratory infections in asthma and asthma exacerbations. Lancet 376: 826-834.
4. Alexopoulou, L., A. C. Holt, R. Medzhitov, and R. A. Flavell. 2001. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 413: 732-738.
5. Doyle, S., S. Vaidya, R. O'Connell, H. Dadgostar, P. Dempsey, T. Wu, G. Rao, R. Sun, M. Haberland, R. Modlin, and G. Cheng. 2002. IRF3 mediates a TLR3/ TLR4-specific antiviral gene program. Immunity 17: 251-263.
6. Lundberg, A. M., S. K. Drexler, C. Monaco, L. M. Williams, S. M. Sacre, M. Feldmann, and B. M. Foxwell. 2007. Key differences in TLR3/poly I:C signaling and cytokine induction by human primary cells: a phenomenon absent from murine cell systems. Blood 110: 3245-3252.
7. Dougherty, R. H., and J. V. Fahy. 2009. Acute exacerbations of asthma: epidemiology, biology and the exacerbation-prone phenotype. Clin. Exp. Allergy 39: 193-202.
8. Jackson, D. J., and S. L. Johnston. 2010. The role of viruses in acute exacerbations of asthma. J. Allergy Clin. Immunol. 125: 1178-1187, quiz 1188-1189.
9. Psarras, S., E. Volonaki, C. L. Skevaki, M. Xatzipsalti, A. Bossios, H. Pratsinis, S. Tsigkos, D. Gourgiotis, A. G. Constantopoulos, A. Papapetropoulos, et al. 2006. Vascular endothelial growth factor-mediated induction of angiogenesis by human rhinoviruses. J. Allergy Clin. Immunol. 117: 291-297.
10. Kuo, C., S. Lim, N. J. King, S. L. Johnston, J. K. Burgess, J. L. Black, and B. G. Oliver. 2011. Rhinovirus infection induces extracellular matrix protein deposition in asthmatic and nonasthmatic airway smooth muscle cells. Am. J. Physiol. Lung Cell. Mol. Physiol. 300: L951-L957.
11. Tacon, C. E., S. Wiehler, N. S. Holden, R. Newton, D. Proud, and R. Leigh. 2010. Human rhinovirus infection up-regulates MMP-9 production in airway epithelial cells via NF-kB. Am. J. Respir. Cell Mol. Biol. 43: 201-209.
12. Al-Muhsen, S., J. R. Johnson, and Q. Hamid. 2011. Remodeling in asthma. J. Allergy Clin. Immunol. 128: 451-462, quiz 463-464.
13. Sugiura, H., X. Liu, F. Duan, S. Kawasaki, S. Togo, K. Kamio, X. Q. Wang, L. Mao, Y. Ahn, R. F. Ertl, et al. 2007. Cultured lung fibroblasts from ovalbuminchallenged "asthmatic" mice differ functionally from normal. Am. J. Respir. Cell Mol. Biol. 37: 424-430.
14. Carroll, N. G., S. Perry, A. Karkhanis, S. Harji, J. Butt, A. L. James, and F. H. Green. 2000. The airway longitudinal elastic fiber network and mucosal folding in patients with asthma. Am. J. Respir. Crit. Care Med. 161: 244-248.
15. Schmidt, M., G. Sun, M. A. Stacey, L. Mori, and S. Mattoli. 2003. Identification of circulating fibrocytes as precursors of bronchial myofibroblasts in asthma. J. Immunol. 171: 380-389.
16. Flood-Page, P., A. Menzies-Gow, S. Phipps, S. Ying, A. Wangoo, M. S. Ludwig, N. Barnes, D. Robinson, and A. B. Kay. 2003. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J. Clin. Invest. 112: 1029-1036.
17. Morishima, Y., A. Nomura, Y. Uchida, Y. Noguchi, T. Sakamoto, Y. Ishii, Y. Goto, K. Masuyama, M. J. Zhang, K. Hirano, et al. 2001. Triggering the induction of myofibroblast and fibrogenesis by airway epithelial shedding. Am. J. Respir. Cell Mol. Biol. 24: 1-11.
18. Sugiura, H., T. Ichikawa, A. Koarai, S. Yanagisawa, Y. Minakata, K. Matsunaga, T. Hirano, K. Akamatsu, and M. Ichinose. 2009. Activation of Toll-like receptor 3 augments myofibroblast differentiation. Am. J. Respir. Cell Mol. Biol. 40: 654-662.
19. Wenzel, S. E., S. Balzar, M. Cundall, and H. W. Chu. 2003. Subepithelial basement membrane immunoreactivity for matrix metalloproteinase 9: association with asthma severity, neutrophilic inflammation, and wound repair. J. Allergy Clin. Immunol. 111: 1345-1352.
20. Bergeron, C., W. Al-Ramli, and Q. Hamid. 2009. Remodeling in asthma. Proc. Am. Thorac. Soc. 6: 301-305.
21. Rajah, R., R. V. Nachajon, M. H. Collins, H. Hakonarson, M. M. Grunstein, and P. Cohen. 1999. Elevated levels of the IGF-binding protein protease MMP-1 in asthmatic airway smooth muscle. Am. J. Respir. Cell Mol. Biol. 20: 199-208.
22. Dolhnikoff, M., L. F. da Silva, B. B. de Araujo, H. A. Gomes, S. Fernezlian, A. Mulder, J. H. Lindeman, and T. Mauad. 2009. The outer wall of small airways is a major site of remodeling in fatal asthma. J. Allergy Clin. Immunol. 123: 1090-1097, e1.
23. Cataldo, D. D., M. Gueders, C. Munaut, N. Rocks, P. Bartsch, J. M. Foidart, A. Noel, and R. Louis. 2004. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab. Invest. 84: 418-424.
24. Hacha, J., K. Tomlinson, L. Maertens, G. Paulissen, N. Rocks, J. M. Foidart, A. Noel, R. Palframan, M. Gueders, and D. D. Cataldo. 2012. Nebulized anti-IL- 13 monoclonal antibody Fab' fragment reduces allergen-induced asthma. Am. J. Respir. Cell Mol. Biol. 47: 709-717.
25. Emonard, H., C. Takiya, S. Dreze, J. F. Cordier, and J. A. Grimaud. 1989. Interstitial collagenase (MMP-1), gelatinase (MMP-2) and stromelysin (MMP-3) released by human fibroblasts cultured on acellular sarcoid granulomas (sarcoid matrix complex, SMC). Matrix 9: 382-388.
26. Karakiulakis, G., E. Papakonstantinou, A. J. Aletras, M. Tamm, and M. Roth. 2007. Cell type-specific effect of hypoxia and platelet-derived growth factor-BB on extracellular matrix turnover and its consequences for lung remodeling. J. Biol. Chem. 282: 908-915.
27. van der Vliet, A., J. P. Eiserich, M. K. Shigenaga, and C. E. Cross. 1999. Reactive nitrogen species and tyrosine nitration in the respiratory tract: epiphenomena or a pathobiologic mechanism of disease? Am. J. Respir. Crit. Care Med. 160: 1-9.
28. Sugiura, H., and M. Ichinose. 2008. Oxidative and nitrative stress in bronchial asthma. Antioxid. Redox Signal. 10: 785-797.
29. Ichikawa, T., H. Sugiura, A. Koarai, S. Yanagisawa, M. Kanda, A. Hayata, K. Furukawa, K. Akamatsu, T. Hirano, M. Nakanishi, et al. 2008. Peroxynitrite augments fibroblast-mediated tissue remodeling via myofibroblast differentiation. Am. J. Physiol. Lung Cell. Mol. Physiol. 295: L800-L808.
30. Sugiura, H., Y. Komaki, A. Koarai, and M. Ichinose. 2008. Nitrative stress in refractory asthma. J. Allergy Clin. Immunol. 121: 355-360.
31. Okamoto, T., T. Akaike, T. Sawa, Y. Miyamoto, A. van der Vliet, and H. Maeda. 2001. Activation of matrix metalloproteinases by peroxynitrite-induced protein S-glutathiolation via disulfide S-oxide formation. J. Biol. Chem. 276: 29596-29602.
32. Sugiura, H., H. Kawabata, T. Ichikawa, A. Koarai, S. Yanagisawa, T. Kikuchi, Y. Minakata, K. Matsunaga, M. Nakanishi, T. Hirano, et al. 2012. Inhibitory effects of theophylline on the peroxynitrite-augmented release of matrix metalloproteinases by lung fibroblasts. Am. J. Physiol. Lung Cell. Mol. Physiol. 302: L764-L774.
33. Garvey, E. P., J. A. Oplinger, E. S. Furfine, R. J. Kiff, F. Laszlo, B. J. Whittle, and R. G. Knowles. 1997. 1400W is a slow, tight binding, and highly selective inhibitor of inducible nitric-oxide synthase in vitro and in vivo. J. Biol. Chem. 272: 4959-4963.
34. Sugiura, H., and M. Ichinose. 2011. Nitrative stress in inflammatory lung diseases. Nitric Oxide 25: 138-144.
35. Sugiura, H., X. Liu, T. Kobayashi, S. Togo, R. F. Ertl, S. Kawasaki, K. Kamio, X. Q. Wang, L. Mao, L. Shen, et al. 2006. Reactive nitrogen species augment fibroblast-mediated collagen gel contraction, mediator production, and chemotaxis. Am. J. Respir. Cell Mol. Biol. 34: 592-599.
36. Batinić-Haberle, I., S. Cuzzocrea, J. S. Rebouças, G. Ferrer-Sueta, E. Mazzon, R. Di Paola, R. Radi, I. Spasojević, L. Benov, and D. Salvemini. 2009. Pure MnTBAP selectively scavenges peroxynitrite over superoxide: comparison of pure and commercial MnTBAP samples to MnTE-2-PyP in two models of oxidative stress injury, an SOD-specific Escherichia coli model and carrageenaninduced pleurisy. Free Radic. Biol. Med. 46: 192-201.
37. Natarajan, K., S. Singh, T. R. Burke, Jr., D. Grunberger, and B. B. Aggarwal. 1996. Caffeic acid phenethyl ester is a potent and specific inhibitor of activation of nuclear transcription factor NF-k B. Proc. Natl. Acad. Sci. USA 93: 9090-9095.
38. McDonald, V. M., and P. G. Gibson. 2012. Exacerbations of severe asthma. Clin. Exp. Allergy 42: 670-677.
39. Wos, M., M. Sanak, J. Soja, H. Olechnowicz, W. W. Busse, and A. Szczeklik. 2008. The presence of rhinovirus in lower airways of patients with bronchial asthma. Am. J. Respir. Crit. Care Med. 177: 1082-1089.
40. START Investigators Group. 2009. Severe exacerbations and decline in lung function in asthma. Am. J. Respir. Crit. Care Med. 179: 19-24.
41. Takayama, S., M. Tamaoka, K. Takayama, K. Okayasu, K. Tsuchiya, Y. Miyazaki, Y. Sumi, J. G. Martin, and N. Inase. 2011. Synthetic doublestranded RNA enhances airway inflammation and remodelling in a rat model of asthma. Immunology 134: 140-150.
42. Tanaka, H., N. Miyazaki, K. Oashi, S. Tanaka, M. Ohmichi, and S. Abe. 2000. Sputum matrix metalloproteinase-9: tissue inhibitor of metalloproteinase-1 ratio in acute asthma. J. Allergy Clin. Immunol. 105: 900-905.
43. Atkinson, J. J., and R. M. Senior. 2003. Matrix metalloproteinase-9 in lung remodeling. Am. J. Respir. Cell Mol. Biol. 28: 12-24.
44. Ritter, M., D. Mennerich, A. Weith, and P. Seither. 2005. Characterization of Toll-like receptors in primary lung epithelial cells: strong impact of the TLR3 ligand poly(I:C) on the regulation of Toll-like receptors, adaptor proteins and inflammatory response. J. Inflamm. (Lond.) 2: 16.
45. Savill, N. J., R. Weller, and J. A. Sherratt. 2002. Mathematical modelling of nitric oxide regulation of rete peg formation in psoriasis. J. Theor. Biol. 214: 1-16.
46. Uematsu, S., and S. Akira. 2007. Toll-like receptors and Type I interferons. J. Biol. Chem. 282: 15319-15323.
47. Fitzgerald, K. A., D. C. Rowe, B. J. Barnes, D. R. Caffrey, A. Visintin, E. Latz, B. Monks, P. M. Pitha, and D. T. Golenbock. 2003. LPS-TLR4 signaling to IRF- 3/7 and NF-kappaB involves the toll adapters TRAM and TRIF. J. Exp. Med. 198: 1043-1055.
48. Ford, E., and D. Thanos. 2010. The transcriptional code of human IFN-beta gene expression. Biochim. Biophys. Acta 1799: 328-336.
49. Lewis, R. S., T. B. Kolesnik, Z. Kuang, A. A. D'Cruz, M. E. Blewitt, S. L. Masters, A. Low, T. Willson, R. S. Norton, and S. E. Nicholson. 2011. TLR regulation of SPSB1 controls inducible nitric oxide synthase induction. J. Immunol. 187: 3798-3805.
50. Domínguez, P. M., M. López-Bravo, U. Kalinke, and C. Ardavín. 2011. Statins inhibit iNOS-mediated microbicidal potential of activated monocyte-derived dendritic cells by an IFN-b-dependent mechanism. Eur. J. Immunol. 41: 3330-3339.
51. Brett, P. J., M. N. Burtnick, H. Su, V. Nair, and F. C. Gherardini. 2008. iNOS activity is critical for the clearance of Burkholderia mallei from infected RAW 264.7 murine macrophages. Cell. Microbiol. 10: 487-498.
52. Ingram, J. L., M. J. Huggins, T. D. Church, Y. Li, D. C. Francisco, S. Degan, R. Firszt, D. M. Beaver, N. L. Lugogo, Y. Wang, et al. 2011. Airway fibroblasts in asthma manifest an invasive phenotype. Am. J. Respir. Crit. Care Med. 183: 1625-1632.
53. Lopez-Souza, N., S. Favoreto, H. Wong, T. Ward, S. Yagi, D. Schnurr, W. E. Finkbeiner, G. M. Dolganov, J. H. Widdicombe, H. A. Boushey, and P. C. Avila. 2009. In vitro susceptibility to rhinovirus infection is greater for bronchial than for nasal airway epithelial cells in human subjects. J. Allergy Clin. Immunol. 123: 1384-1390.e1382.
54. Bradley, L. M., M. F. Douglass, D. Chatterjee, S. Akira, and B. J. Baaten. 2012. Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog. 8: e1002641.
55. Lee, Y. H., C. L. Lai, S. H. Hsieh, C. C. Shieh, L. M. Huang, and B. A. Wu-Hsieh. 2013. Influenza A virus induction of oxidative stress and MMP-9 is associated with severe lung pathology in a mouse model. Virus Res. 178: 411-422.